Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
A rapid and automated method for discovering potential drugs for the treatment of sickle cell anemia, using a combination of laser photolysis and statistical processing of digital images. More
A simple assay to validate and quantify allele-specific silencing More
This invention provides the human gene for Niemann-Pick Type C disease and the nucleic acid sequences corresponding to the human gene for Niemann-Pick Type C disease. More
A possible treatment of laminopathies, cellular aging and aging-related conditions such as HGPS through the use of farnesyltransferase inhibitors (FTIs) and other related compounds More
The proposed invention will provide a competitive advantage to any company or organization involved with the regulation of gene expression, cancer research, rational drug design, or any research and development More
Genetic Test Predictive of Severity of Cystic Fibrosis Pulmonary Disease More
Genetic Association of Familial Combined Hyperlipidaemia for Diagnostic and Pharmacogenomic uses More
Epigenetic Biomarkers for the Minimally Invasive Diagnosis of Foetal Genetic Disease More
Polymorphism and Genetic Susceptibility to Thyroid Dysgenesis: For Diagnosis an Increased Likelihood of Developing a TD More
The Role of the Cholesterol Transport Gene in the Intestinal Transport of Cholesterol: Screening for Novel Cholesterol-Lowering Drugs More
Related Reports
Market Research Reports provided by reports.iptechex.com
Apr 2011 - 26 pages - $500
Jul 2011 - 136 pages - $500
Nov 2010 - 40 pages - $500
Feb 2011 - 209 pages - $3,500
May 2011 - 34 pages - $500
Apr 2011 - 56 pages - $3,800
Dec 2010 - 22 pages - $500
Oct 2011 - 27 pages - $500
May 2011 - 23 pages - $500
Mar 2011 - 47 pages - $500
Your selection
Browse By
- Industry sector
- Bioinformatics
- Combinatorial biology
- Combinatorial chemistry
- Drug research platforms
- Genomics
- High throughput screening
- Proteomics
- Therapeutic target
- Birth defects
- Blood clotting disorders
- Fabry's disease
- Gaucher's disease
- Genetic disorder (other)
- Hunter's syndrome
- Huntington's disease
- Kawasaki disease
- Klinefelter's syndrome
- Phenylketonuria
- Severe combined immunodeficiency
- Turner's syndrome
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us